Molnupiravir (Lagevrio) 200mg 40 Capsules

Prescription only Generic
$126.50
Active Ingredient : Molnupiravir
Molnupiravir (Lagevrio) 200mg 40 Capsules

Reliable shipping

Flexible returns

Dispensing Country : India
Zoomed

Molnupiravir (Lagevrio) is an innovative antiviral medication designed to treat COVID-19. This treatment option has garnered attention for its role in managing mild to moderate cases of the virus in adults who are at high risk of developing severe illness. Each capsule contains 200mg of Molnupiravir, ensuring a potent dosage to effectively combat the virus.



Key highlights of Molnupiravir include:



  • Mechanism of Action: Molnupiravir works by interfering with the replication of the SARS-CoV-2 virus, helping to reduce viral load and potentially mitigating the severity of the disease.

  • Administration: The medication is administered orally, providing a convenient and user-friendly option for patients. It is typically prescribed to be taken twice daily for five days.

  • Clinical Efficacy: Clinical trials have demonstrated that Molnupiravir can significantly lower the risk of hospitalization and death among at-risk patients, making it a vital tool in the fight against COVID-19.

  • Accessibility: As a prescription medication, it is important for patients to consult with their healthcare provider to determine if Molnupiravir is suitable for their specific health needs.

  • Side Effects: While generally well-tolerated, some patients may experience mild side effects. Commonly reported effects include diarrhea, nausea, and headache.

  • Importance of Early Treatment: For optimal effectiveness, it is crucial to start treatment with Molnupiravir as soon as possible after a positive COVID-19 test or the onset of symptoms.



As the pandemic continues to evolve, Molnupiravir stands out as a significant advancement in antiviral therapy, offering hope to those at risk of severe COVID-19 outcomes.


  • Molnupiravir

  • Inactive ingredients:


    • Microcrystalline cellulose

    • Magnesium stearate

    • Hydroxypropyl methylcellulose

    • Triacetin

    • Iron oxide red

    • Iron oxide yellow


Molnupiravir (Lagevrio) is an antiviral medication used for the treatment of COVID-19. It is important to follow the prescribed guidelines for its use to ensure safety and effectiveness.



Before starting the treatment, consult your healthcare provider to confirm that Molnupiravir is appropriate for your condition. Make sure to inform them of any allergies or other medications you are currently taking.




  1. Dosage: Take Molnupiravir exactly as prescribed by your doctor. The typical dosage is four capsules (200 mg each) taken twice daily for five days. Do not exceed the recommended dose.

  2. Administration: Swallow the capsules whole with water. Do not crush, chew, or open the capsules, as this may affect the medication's effectiveness.

  3. Timing: Try to take the capsules at the same times each day to maintain consistent levels of the medication in your body. Setting reminders on your phone or using a pill organizer can help.

  4. With or without food: Molnupiravir can be taken with or without food. If you experience stomach upset, taking it with food may reduce discomfort.

  5. Missed dose: If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not take two doses at once.

  6. Completion of treatment: Complete the full course of treatment even if you start feeling better. Stopping early may allow the virus to continue to spread and develop resistance.



Monitor for any side effects, such as nausea, diarrhea, or dizziness. If you experience severe side effects or an allergic reaction (such as rash, itching, or difficulty breathing), seek medical attention immediately.



Keep Molnupiravir in its original packaging and store it at room temperature, away from moisture and heat. Ensure it is out of reach of children and pets.



Always follow your healthcare provider's recommendations and attend any follow-up appointments to assess your response to the treatment.

You may also like